Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-26-019804

Chief Development Officer sold 2,810 shares at $8.28 ($23,267)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kaiser Peter · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-23 Sale : show line 1 in the form 10b5-1 −2,810 $8.28 $23,267 269,108 D
Open-market sales · 2,810 sh · avg $8.28 · $23,267
Loading xslF345X05/tm267255-3_4seq1.xml…